Former ONE Championship and UFC flyweight champion 'Mighty Mouse' Demetrious Johnson's legendary mixed martial arts career may have concluded, but the 38-year-old icon still looks back fondly on ...
Demetrious Johnson made a stop in Thailand last week to film a new episode of the Mighty podcast. Along the way, he chose to spend time and train with Rodtang Jitmuangnon before attending the ...
Demetrious Johnson considers Renato "Money Moicano" Carneiro (20-5) to be a dangerous opponent for Islam Makhachev (26-1). The UFC 311 main event saw a last-minute change as Arman Tsarukyan was forced ...
Hosted on MSN7d
“That’s Why They’re One of the Best” – Demetrious Johnson Gives Inside Scoop on Training With Team Khabib Before UFC 311 [Exclusive]What’s it like to train with UFC Hall of Famer Khabib Nurmagomedov and his legendary team of Dagestani fighters? The post ...
Bryan Johnson has dropped the medicine he had been taking for last five years. Bryan Johnson, the 47-year-old tech entrepreneur who has spent millions on his quest to reverse his biological age ...
The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.
Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...
NEW BRUNSWICK, N.J. and BEDMINSTER, N.J., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Johnson & Johnson (NYSE: JNJ) and Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) announced ...
Anti-aging advocate Bryan Johnson, who gulps down 54 pills for breakfast, recently discovered a wrinkle in his meticulous approach to dodging death. Every two weeks, the 47-year-old tech ...
Johnson & Johnson has opened the J.P. Morgan Healthcare Conference with a bang, buying out Intra-Cellular Therapies for $14.6 billion. At $132 per share, J&J paid a 39% premium on Friday’s ...
Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...
Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback